India's Sun Pharmaceutical Industries Ltd has received a tentative approval from the US Food and Drug Administration for rivastigmine capsules, a drug for Alzheimer's, the agency said in a statement.
HT Image
Sun shares rose 0.9 per cent to Rs 874 in a firm Mumbai market